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Role of Keratinocytes in the Development of Vitiligo
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Department of Dermatology, Dongguk University Ilsan Hospital, Dongguk University Graduate School of Medicine, Goyang, Korea
Vitiligo is an acquired depigmentary disorder of the skin that 
results from the loss of functioning epidermal melanocytes. 
Most studies on vitiligo have concentrated on the abnor-
mality of melanocytes rather than the abnormality of 
keratinocytes; however, epidermal melanocytes form a 
functional and structural unit with neighboring keratino-
cytes. In fact, direct cell-to cell contact stimulates in vitro 
proliferation of melanocytes, and growth factors produced 
by adjacent keratinocytes regulate the proliferation and 
differentiation of melanocytes. The potential role of 
keratinocyte-derived cytokines has also been presented. We 
focused on the structural changes in vitiliginous kerati-
nocytes, which may result in loss of melanocytes, to examine 
the pathomechanism of vitiligo. The results of a comparison 
between depigmented and normally pigmented epidermis 
in patients with vitiligo showed that the keratinocytes in the 
depigmented epidermis were more vulnerable to apoptosis. 
Impaired Phosphatidylinositol 3-kinase (PI3K)/serine/threonine 
protein kinase (Akt) activation followed by reduced nuclear 
factor-κB activation under increased tumor necrosis factor-
α  levels was demonstrated as a mechanism for keratinocyte 
apoptosis. The role of aquaporin 3 in keratinocyte apoptosis 
was addressed based on the relationship between the 
PI3K/AKT pathway and the E-cadherin-catenin complex. 
Apoptotic keratinocytes induced a lower expression of 
keratinocyte-derived factors, including stem cell factor, in 
depigmented epidermis, resulting in passive melanocyte 
death. (Ann Dermatol 24(2) 115∼125, 2012)
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INTRODUCTION
Vitiligo is an acquired depigmentary disorder of the skin 
resulting from the loss of functioning epidermal melano-
cytes. The etiology involves multiple pathogenetic factors, 
including neural theory, impaired antioxidative defenses, 
mitochondrial membrane lipid peroxidation, a link and 
temporal sequence between oxidative stress and auto-
immunity, and a genetic predisposition, most of them 
acting in concert
1,2.
Most studies on vitiligo have concentrated on the abnor-
mality of melanocytes rather than the abnormality of kera-
tinocytes, although epidermal melanocytes form a func-
tional and structural unit with neighboring keratinocytes. 
Cell-to cell interactions play an important role in homeo-
stasis and regeneration of adult tissues. Cross-talk between 
has been observed between keratinocytes and melano-
cytes. In fact, direct cell-to-cell contact stimulates in vitro 
proliferation and differentiation of melanocytes
3. Growth 
factors produced by adjacent keratinocytes regulate the 
proliferation and differentiation of melanocytes
3. Therefore, 
damage to keratinocytes might have a significant effect on 
melanocyte survival. Autologous epidermal grafting is a 
popular surgical method to replace melanocytes and treat 
stable vitiligo. Although a similar number of melanocytes 
is transferred to depigmented epidermis, the outcome of 
transferred melanocytes would be different; melanocytes 
may survive by proliferation resulting in homogenous 
pigmentation, may survive without producing homo-
genous pigmentation, or may survive temporarily and then 
die (Fig. 1). In addition, complete homogenous pigmenta-
tion is usually restored at the donor sites. These results 
suggest that local factors participate in the survival and/or AY Lee
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Fig. 1. Outcome of an autologous epidermal graft using a suction blister. Although a similar number of melanocytes were transferred 
to the recipient sites (arrow heads and arrows) of patients with stable vitiligo, different outcomes, such as complete repigmentation 
with peripheral extension (left), pigmentation mottling (middle), and failure of repigmentation (right), were observed.
growth of melanocytes. Because depigmented epidermis 
contains only a few 3,4-dihydroxyphenylalanine-positive 
melanocytes or none at all, resident keratinocytes may be 
the main source of local factors. Although structural 
abnormalities in keratinocytes are not remarkable in hema-
toxylin and eosin (H & E)-stained epidermal specimens in 
patients with vitiligo, structural changes and their effect on 
vitiligo development are presented in this study. 
APOPTOSIS OF VITILIGINOUS 
KERATINOCYTES
A loss or a decrease of pigmentation is the main clinical 
finding in patients with vitiligo. No remarkable micro-
scopic changes, except decreased or no melanocytes, are 
observed on H & E staining. Nonetheless, an electron 
microscopic examination showed that basal and parabasal 
keratinocytes degenerate, not only in depigmented but 
also in normally pigmented skin
4,5. The fine structural 
changes of degeneration seemed to be consistent with 
either early signs of cellular necrosis or apoptosis. Addi-
tionally, anti-keratinocyte antibodies, which have been 
detected in the sera of patients with vitiligo, result from 
keratinocyte death during the disease process
6. We also 
previously examined cytokeratin expression using paired 
depigmented and normally pigmented epidermis obtained 
from suction blisters of patients with vitiligo. Western 
blotting showed more numerous lower molecular weight 
keratin bands, which are not detected in cultured normal 
keratinocytes either a high or lower calcium concen-
tration, in depigmented compared to normally pigmented 
epidermal specimens (data not shown). Although it is 
unclear how these lower molecular weight bands 
developed, increased keratin proteolysis
7 and limited 
capacity for in vitro polymerization
8 have been suggested. 
In fact, abnormal cytokeratin expression profiles displaying 
an increase in lower molecular weight polypeptides have 
been reported for psoriasis
9. Based on these results, we 
examined and compared the differences in keratinocytes 
between depigmented and normally pigmented epider-
mis, particularly focusing on keratinocyte apoptosis.
Apoptosis is a distinct mode of cell death, which differs 
from necrosis in morphology and mechanism, and plays a 
crucial role in homeostasis. Apoptosis is characterized by 
cell shrinkage, chromatin condensation, and systemic 
DNA cleavage and is triggered by various physiological 
stimuli such as Fas/tumor necrosis factor (TNF) receptors 
and the loss of survival stimuli
10. As apoptotic cells are 
rapidly engulfed by phagocytes, thereby preventing an 
inflammatory reaction to the degenerative cell contents
11, Keratinocyte Role in Vitiligo
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Fig. 2. The terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end-labeling of DNA fragments 
(TUNEL) assay in depigmented and normally pigmented epidermis. The TUNEL assay showed more TUNEL-positive apoptotic cells
emitting green fluorescence in the depigmented (lesional, L) compared to the normally pigmented (normally pigmented, N) epidermis.
Nuclei were counterstained in blue with Hoechst 33258 (×200).
specific methods such as cell morphology, DNA degra-
dation analysis, DNA end labeling techniques, flow 
cytometric analyses, and nuclease assays have been 
developed to detect them. Externalization of phosphati-
dylserine (PS) and phosphatidylethanolamine is a hallmark 
of the changes in the cell surface during apoptosis
12,13. 
Permeability of the plasma membrane is also a central 
difference between necrosis and apoptosis. Based on 
these results, Annexin V binding as a marker of PS exter-
nalization
14, large molecular weight DNA binding dyes, 
such as propidium iodide, and smaller dyes, such as 
4-6-diamidino-2-phenylindole, Hoechst 33342 or 33258, 
have been used singly or in combination to detect 
apoptosis
15,16. However, these assays are only applicable 
to study isolated cells but not intact tissues. In contrast, 
methods for detecting the 3'- OH ends of single-stranded 
DNA breaks, such as terminal deoxynucleotidyl 
transferase-mediated deoxyuridine triphosphate-biotin 
nick end-labeling of DNA fragments (TUNEL) methods, 
are directly applicable to intact tissue sections. In fact, 
TUNEL is a method to simplify the identification of 
apoptotic nuclei in routinely processed tissue sections
17. 
Therefore, we performed TUNEL staining using paired 
depigmented and normally pigmented skin specimens of 
patients with vitiligo. The staining revealed that the 
number of TUNEL- positive cells increased significantly in 
the basal layers of depigmented compared to normally 
pigmented epidermis, which was taken from either 
suction blisters (Fig. 2) or skin biopsies
18,19. Because most 
TUNEL-positive cells in the epidermis did not stain for 
c-kit, a marker of melanocytes, the TUNEL-positive cells 
were considered to have originated from keratinocytes. 
However, TUNEL positivity does not always mean 
apoptosis. The TUNEL method might detect cells that 
have not shown DNA fragmentation specific for apoptosis 
only, but identifies nuclei in areas of necrosis
17.
Apoptosis is the best characterized form of programmed 
cell death. Two major pathways are involved in the 
initiation of apoptosis in mammalian systems, the extrinsic 
death receptor pathway and the intrinsic mitochondrial 
pathway. Caspases are central effectors in the apoptotic 
signaling pathways, which include the initiation, media-
tion, execution, and regulation of apoptosis. Caspases are 
a family of mammalian proteases that mediate many of the 
morphological and biochemical features of apoptosis. The 
caspases are synthesized as inactive zymogens whose 
activation requires limited proteolysis or binding to 
co-factors
20. The extrinsic pathway is initiated by recruit-
ment and activation of caspase-8 in the death-inducing 
signaling complex (DISC) followed by direct cleavage of 
downstream effector caspases. In contrast, release of a 
number of pro-apoptotic factors from the intermembrane 
space of mitochondria is preceded by the activation of 
caspase-9 in the intrinsic pathway
21. Both the extrinsic and 
the intrinsic apoptosis signaling pathways converge into a 
common pathway resulting in the activation of the 
executioner caspase cascade including caspase-3. The 
TUNEL-positive cells in skin specimens of patients with 
vitiligo were stained with anti-active caspase-3 antibody. 
A Western blot analysis showed that active forms of 
caspase-9, caspase-8, and caspase-3 were higher in depig-
mented epidermis when compared to normally pigmented AY Lee
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Fig. 3. Immunofluorescence staining of paired suction-blistered epidermis samples with anti-tumor necrosis factor (TNF)-α antibody.
(A, E) without staining; (B, F) staining of nuclei with Hoechst 33258; (C, G) staining with anti-TNF-α antibody; (D, H) staining with
anti-TNF-α antibody (green) and counterstaining of nuclei with Hoechst 33258 (blue) (A~D) in the normally pigmented epidermal
specimens. Cells were weakly stained with anti-TNF-α antibody. (E~H) in the depigmented epidermal specimens. More cells stained
strongly with anti-TNF-α antibody. The strong TNF-α-positive cells were mainly found in the lower layer (A∼H, ×200).
epidermis in patients with vitiligo
18. Although active 
caspase-3 has been detected in the transition zone 
between the granular and cornified layers of normal 
human epidermis
22, it has not been detected in the basal 
layers of the epidermis where the TUNEL-positive apoptotic 
cells were found. Therefore, the TUNEL-positive implies 
an apoptotic process.
Regulation of apoptosis is an important part of the apop-
totic signaling pathways. Pro-apoptotic and anti-apoptotic 
members of the Bcl-2 family proteins are involved in the 
regulation. Bcl-2 and Bcl-xL preserve mitochondrial inte-
grity and prevent release of pro-apoptic proteins such as 
cytochrome c into the cytosol, whereas Bax and Bak pro-
mote release of cytochrome c. TUNEL-positive cells in 
epidermis from patients with vitiligo were also stained 
with anti-Bax antibody. The levels of Bax expression are 
higher, whereas those of Bcl-2 are lower in the depig-
mented compared to normally pigmented epidermis
18. 
Because of the higher levels of Bcl-2 expression in mela-
nocytes and lower levels in keratinocytes
23, the lower 
levels of Bcl-2 in the depigmented epidermis may result 
from the loss of melanocytes
18. The Bcl-2 family member 
Bid, which connects between the extrinsic and intrinsic 
pathways after cleavage by caspase-8, is a target of the 
p53 tumor suppressor
24. Whenever p53 is triggered, cell 
growth is arrested or apoptosis is induced. However, X- 
linked inhibitor of apoptosis protein and FLICE (fas- 
associated death domain protein-like interleukin [IL]-1- 
beta-converting enzyme)-like inhibitory proteins (FLIPs) 
block the activation of caspases, particularly those 
involved in the extrinsic pathway
25. Cellular FLIP is 
homologous to caspase-8 and is also recruited to the 
DISC, resulting in interference with caspase-8 activation at 
the DISC
26. As keratinocytes express higher levels of the 
anti-apoptotic protein FLIP and the pro-apoptotic protein 
p53 rather than Bcl-2 and Bax expression in the 
melanocytes
23, the levels of FLIP and p53 were also 
examined in the vitiligo epidermis. The result showed that 
the levels of FLIP were lower and those of p53 were 
higher in the depigmented epidermis
18. Keratinocyte Role in Vitiligo
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Fig. 4. (A, B) Schematic view of the
Fas/Fas-ligand (FasL) apoptotic signal-
ing pathway. Fas can be activated by
FasL, which leads to caspase-8 acti-
vation and triggers extrinsic apop-
tosis. Caspase-8 cleaves Bid, genera-
ting a truncated form, tBid, and then
releasing cytochrome c from mito-
chondria, which triggers intrinsic apop-
tosis. TNF-R: tumor necrosis factor 
receptor.
IMPAIRED PI3K/AKT ACTIVATION IN 
KERATINOCYTE APOPTOSIS 
Although more apoptotic keratinocytes occur in the 
depigmented epidermis, it is unclear how keratinocyte 
apoptosis occurs in patients with vitligo. In the non- 
segmental type vitiligo, depigmented maculopatches 
could develop on areas corresponding to trauma
27, which 
includes mechanical trauma such as repeated friction
28, 
chemical damage, or ultraviolet (UV) radiation. Although 
the mechanism of koebnerization is unclear, it may be 
expected that some inflammation would precede the 
development of isomorphic depigmentation. In fact, a 
histological examination of non-segmental vitiligo skin 
shows prominent inflammatory cells in perilesional areas, 
which are primarily composed of CD3+, CD4+, and 
CD8+ T cells
29,30, although definite inflammation is rare 
in patients with vitiligo. A correlation between perile-
sional T-cell infiltration and melanocyte loss in situ has 
also been observed
31,32. Additionally, there are signifi-
cantly higher levels of TNF-α, IL-1α, and IL-6 in depig-
mented than in perilesional, non-lesional, and healthy 
skin
33,34, suggesting that cytokines are important in the 
depigmentation process as potent inhibitors of melanocyte 
growth in patients with vitiligo
33,35. 
TNF-α is a key initiator of inflammation that increased in 
the depigmented compared to normally pigmented epi-
dermis (Fig. 3). This member of the TNF superfamily of 
cytokines is at the center of the extrinsic pathway of 
apoptosis. The extrinsic pathway is triggered by the bindi-
ng of death ligands of the TNF family to their appropriate 
death receptors on the cell surface. This, in turn, recruits 
initiator caspases, giving rise to the pro-apoptotic complex 
termed DISC. Death receptors (DRs) include TNF-α 
receptor 1 (TNF-R1), Fas, DR3, DR4 (TNF-related apoptosis 
inducing ligand-R1; TRAIL-R1), DR5 (TRAIL-R2), and DR6, 
whereas death ligands include TNF-α, Fas-ligand (FasL), 
Apo3-ligand, TRAIL, and lymphotoxin
36. TNF-α acts through 
TNF-α  receptors. TNF-R1 recruits TNF-R1-associated 
death domain protein
37, which is coupled to two recep-
tors, Fas-associating protein and TNF-R1-associated factor 
2 (TRAF2). 
Apoptotic and non-apoptotic signaling occur upon bind-
ing of other DRs and ligands. Although more interest have 
been recently focused on TRAIL and its receptors due to 
preferential apoptosis of transformed cells and the absence 
of severe toxicity, the Fas/FasL system is a prototypic 
inducer of extrinsic cell death (Fig. 4). Therefore, we 
examined only Fas/FasL in patients with vitiligo. Fas can 
be activated by FasL, and we found that the expression of 
FasL and TNF-α increased in the depigmented compared 
to that in the normally pigmented epidermis
38. Fas/FasL 
leads to recruitment and activation of caspase-8 in the 
DISC followed by direct cleavage of downstream effector 
caspases
21,39,40. Although intrinsic and extrinsic pathways 
are separate, there is cross talk between the two pathways. 
The best characterized connection is the Bcl-2 family 
member Bid (Fig. 4). In fact, caspase-8 cleaves Bid, 
generating a truncated form, tBid
41,42, which, in turn, 
translocates to mitochondria and induces the release of 
caspase-activating factors including cytochrome c from 
mitochondria, triggering intrinsic apoptosis
43. The impact AY Lee
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Fig. 5. Schematic view of apoptotic pathways in vitiliginous
keratinocytes. Tumor necrosis factor (TNF)-α is supposed to 
activate phosphatidylinositol 3-phosphate (PI3K)/apoptosis
signal-regulating kinase (AKT), which, in turn, activates nuclear 
factor (NF)-κB through sequential activation of Iκβ kinases 
(IKKs) and inhibitor-κB (I-κB), resulting in inhibiting apoptosis.
However, activation of AKT and NF-κB was reduced in 
depigmented epidermis, whereas the Fas/Fas-ligand (FasL) 
pathway was normal. FLIP: FLICE (fas-associated death domain
protein-like interleukin-1-beta-converting enzyme)-like inhibitory
proteins.
Fig. 6. Activation of apoptosis signal-regulating kinase (AKT) 
requires initiation of keratinocyte differentiation. Targeted reduc-
tion of AKT1/phosphatidylinositol 3-kinase (PI3K) a ctivation 
increases the susceptibility of keratinocytes to apoptosis, with 
selective death of differentiating keratinocytes.
of these two apoptotic pathways could be enhanced when 
they converge through Bid. In contrast, binding to the 
TRAF2 activates phosphatidylinositol 3-kinases (PI3K) and 
its downstream target apoptosis signal-regulating kinase 
(AKT)
44, which, in turn, activates NF-κB
45,46 through 
sequential activation of I-κB kinases and I-κB. These 
non-apoptotic signaling pathways result in inhibiting 
apoptosis. Although non-apoptotic signal transduction was 
induced by the DRs and ligands system such as Fas/FasL, 
AKT and nuclear factor (NF)-κB activation decreased in 
the depigmented epidermis (Fig. 5). In addition, inhibiting 
AKT phosphorylation in cultured normal human 
keratinocytes treated with TNF-α in the presence of a 
PI3K inhibitor resulted in a significant decrease in NF-κB 
phosphorylation with an increase in apoptotic cells. 
Targeted reduction of AKT1 expression results in signifi-
cant cell death in the suprabasal layers
47, and inhibiting 
PI3K increases the susceptibility of keratinocytes to apop-
tosis, with selective death of differentiating keratinocytes 
(Fig. 6)
48. Overall, increased apoptosis of vitiliginous 
keratinocytes could result from reduced activation of NF-
κB via impaired PI3K/AKT activation under increased 
TNF-α  levels
46.
REDUCED AQUAPORIN3 (AQP3) DURING 
APOPTOSIS OF VITILIGINOUS 
KERATINOCYTES
Activation of PI3K depends on both E-cadherin-dependent 
cell adhesion and tyrosine phosphorylation events
49,50. 
The intracellular domain of E-cadherin binds directly to β- 
catenin and γ-catenin. The N-terminal portions of both 
β- and γ-catenin interact with α-catenin, which links 
E-cadherin to the underlying actin cytoskeleton. We 
showed that treatment with the PI3K inhibitor, wort-
mannin, inhibited E-cadherin-catenin expression and PI3K 
phosphorylation in cultured keratinocytes
51. Cadherin is 
involved in the calcium-dependent cell-to-cell adhesion of 
molecules. Increases in intracellular calcium could recruit 
PI3K to the E-cadherin-catenin complex at the plasma 
membrane
52, resulting in PI3K activation. Because acti-
vation of the PI3K/AKT pathway is required for kerati-
nocyte differentiation
53, E-cadherin plays a pivotal role in 
keratinocyte differentiation and cell-to cell adhesion
54,55, 
we previously showed that phosphorylated PI3K de-
creased in the depigmented epidermis of patients with 
vitiligo compared to that in normally pigmented epider-
mis
38. Additionally, we identified that AKT1 phosphory-
lation and E-cadherin, β-catenin, and γ-catenin expre-
ssion decreased significantly in depigmented epidermis
51.
We performed a microarray analysis to compare the 
cultured keratinocytes from normally pigmented epi-
dermis and depigmented epidermis. There was a 2-fold or 
greater down-regulation of AQP3 expression in the kera-
tinocytes from depigmented epidermis, which was 
confirmed by Western blot analysis and immunohisto-
chemistry using paired epidermal specimens obtained 
from 10 patients with vitiligo
51. AQP3 has been identified 
in multiple epithelial tissues as a transmembrane protein Keratinocyte Role in Vitiligo
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Fig. 7. Functional link between aquaporin (AQP) 3 and E-cadherin. Double staining using anti-AQP3 and E-cadherin (E-cad) antibodies 
(A) in the depigmented (lesional, L) and normally pigmented (normally pigmented, N) epidermis from skin biopsies (×200) (B) of 
cultured keratinocytes in the absence of (control) and presence of AQP3 knockdown small interfering RNA (siRNA) (×1,000).
localized to the basolateral membrane
56. AQP3 is detected 
in the epidermal keratinocytes below the stratum corneum 
and is involved in skin hydration
57. Although the role of 
AQP3 in patients with vitiligo is unknown, basolateral 
membrane AQP3 is delivered to post-Golgi structures 
directly to form cell-to-cell contacts, where it co-accumulates 
with E-cadherin
58. Activation of PI3K depends on both 
E-cadherin-dependent cell adhesion and tyrosine phos-
phorylation events
49,50. PI3K/AKT1 phosphorylation and 
the expression of E-cadherin-catenin complex are reduced 
in patients with vitiligo
51. Therefore, a connection between 
AQP3 and PI3K through the E-cadherin-catenin complex 
should be considered. Particularly, the role of AQP3 in 
keratinocyte apoptosis was examined using cultured 
normal human keratinocytes with or without transfection 
of AQP3 small interfering RNA (siRNA)
51, because im-
paired PI3K/AKT activation is involved in vitiliginous 
keratinocyte apoptosis
38. Western blot analysis showed 
that AQP3 siRNAs in cultured normal human keratino-
cytes decreased PI3K-p85α phosphorylation significantly, 
a regulatory subunit of class 1A PI3K, and the expression 
of E-cadherin, β-catenin and γ-catenin. Immunopre-
cipitation using PI3K-p85α also showed reduced binding 
of E-cadherin-catenins to PI3K-p85α
51. These results 
suggest impaired cell-to-cell adhesion. In addition, 
immunohistochemistry using patient’s skin showed that 
expression of the AQP3 protein, which was localized to 
the cell borders of viable cells, decreased in depigmented 
epidermis. Therefore, co-localization of AQP3 and E-cadherin 
was examined by double staining of cultured kerati-
nocytes and vitiligo epidermal specimens using anti-AQP3 
and E-cadherin antibodies. A functional link between 
AQP3 and E-cadherin was identified as expression of 
AQP3 and E-cadherin decreased at the cell-to-cell contacts 
in the depigmented epidermis (Fig. 7A) as well as in the 
cultured AQP3 knockdown keratinocytes (Fig. 7B)
51. A 
similar E-cadherin staining pattern has been briefly 
mentioned in lesional, non-lesional, and normal skin
59. AY Lee
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Fig. 8. Schematic view of the role of apoptotic keratinocytes in
vitiligo. Keratinocytes produce and release numerous synergistic 
mitogens in culture, such as stem cell factor (SCF), endothelins 
(ETs), basic fibroblast growth factor (bFGF). In contrast, apoptotic
keratinocytes provide these growth factors less than that of 
normal keratinocytes, inducing passive melanocyte death due to
the loss of survival stimuli.
Inhibiting cadherin increases apoptosis
55; therefore, the 
association between AQP3 knockdown and reduced cell 
survival was expected. AQP3 knockdown in cultured 
normal human keratinocytes decreased the number of 
surviving keratinocytes at low and high calcium concen-
trations
51. Collectively, the reduced AQP3 in vitiliginous 
keratinocytes could be responsible for their reduced 
survival
51.
ROLE OF KERATINOCYTE APOPTOSIS IN 
DEPIGMENTATION OF VITILIGO 
Cell-to-cell interactions play an important role in hom-
eostasis and regeneration of adult tissues. Crosstalk be-
tween keratinocytes and melanocytes has been observed. 
Actually, direct cell-to-cell contact stimulates in vitro 
proliferation of melanocytes, and growth factors produced 
by adjacent keratinocytes regulate the proliferation and 
differentiation of melanocytes
60. Keratinocytes produce 
and release numerous synergistic mitogens in culture, 
such as basic fibroblast growth factor (bFGF), endothelins, 
stem cell factor (SCF), hepatocyte growth factor, nerve 
growth factor, granulocyte macrophage colony stimulating 
factor, leukemia inhibitory factor, α-melanocyte stimulating 
hormone, and adrenocorticotrophic hormone
61. In particular, 
SCF is essential for melanocyte survival. Melanocytes 
express c-kit
62, a receptor for SCF
63. SCF regulates prolife-
ration and differentiation in neonatal mouse epidermal 
melanocytes in culture with a cyclic adenosine mono-
phosphate stimulator and bFGF
64. SCF exists as membrane- 
bound and soluble forms
65. The proportion of each form is 
dependent on SCF mRNA, which is either full-length or 
alternatively spliced and lacking the exon 6 coding region, 
and on protease activity, which attacks a protease- 
sensitive site in exon 6
66. Normal human keratinocytes 
express both forms of SCF mRNAs
67. In our experience, 
SCF mRNA is maintained as long as sufficient cells are 
alive, which was more than 3 days in melanocyte culture 
medium. The number of cultured normal human melano-
cytes increased in the presence of human keratinocytes 
and/or SCF, whereas the number decreased in a dose- 
dependent manner following treatment with an anti-SCF 
antibody
60. 
It could be expected that keratinocyte apoptosis reduces 
these factors for melanocyte growth. Apoptosis of cultured 
normal human keratinocytes has been induced by UV 
radiation or treatment of H2O2 or staurosporine. Parti-
cularly, staurosporine induces apoptosis in all nucleated 
mammalian cell types
68, regardless of the state of 
differentiation or the cell-cycle phase. Treatment with 
staurosporine induced keratinocyte apoptosis of in a 
dose-dependent manner
60. More importantly, SCF mRNA 
and protein expression decreases with increasing pro-
portions of apoptotic keratinocytes
60. We showed pre-
viously that more keratinocytes in the depigmented epi-
dermis were apoptotic compared to that in normally 
pigmented epidermis
18,38,51. Therefore, lower levels of 
keratinocyte-derived melanocyte growth factors, including 
SCF, were expected in the depigmented epidermis of 
patients with vitiligo. A Western blot analysis showed that 
SCF and bFGF protein expression levels were significantly 
lower in the depigmented epidermis than those in the 
normally pigmented epidermis of patients with vitiligo
60. 
These results agree with those from an immunohisto-
chemistry-based study that demonstrated significantly 
lower expression of SCF and endothelin-1 in lesional skin 
compared with perilesional or nonlesional skin in patients 
with vitiligo
19,33. Withdrawal of the relevant trophic 
substances results in a rapid decrease in cell number, and 
apoptosis has been implicated and identified as the 
mechanism responsible for reducing cell number after 
withdrawal of the mitogenic stimulus
69-71. A reduction in 
melanocyte growth factors including SCF resulting from 
apoptotic death of keratinocytes could provide a circum-
stance for withdrawal of a mitogenic stimulus. Removal of 
either keratinocyte feeder or exogenous SCF from mela-
nocytes cultured in both results in melanocyte apoptosis
60. 
Overall, keratinocyte apoptosis could induce at least the 
loss of survival stimuli (Fig. 8), and then passive melano-
cyte death. Keratinocyte Role in Vitiligo
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CONCLUSIONS
Vitiligo is not a disease confined to melanocytes. As func-
tional and structural units with melanocytes, keratinocytes 
in depigmented epidermis may constitute a different 
microenvironment compared to those in normally pig-
mented epidermis. These differences could induce less 
keratinocyte-derived melanocyte growth factor produc-
tion, resulting in passive melanocyte death with the 
development of vitiligo.
ACKNOWLEDGMENT
This work was supported by the National Research 
Foundation of Korea (NRF) grant funded by the Korea 
government (MEST) [No. 2011-0028962].
REFERENCES
1. Namazi MR. Neurogenic dysregulation, oxidative stress, 
autoimmunity, and melanocytorrhagy in vitiligo: can they be 
interconnected? Pigment Cell Res 2007;20:360-363.
2. Guerra L, Dellambra E, Brescia S, Raskovic D. Vitiligo: 
pathogenetic hypotheses and targets for current therapies. 
Curr Drug Metab 2010;11:451-467.
3. Sviderskaya EV, Wakeling WF, Bennett DC. A cloned, 
immortal line of murine melanoblasts inducible to differen-
tiate to melanocytes. Development 1995;121:1547-1557.
4. Moellmann G, Klein-Angerer S, Scollay DA, Nordlund JJ, 
Lerner AB. Extracellular granular material and degeneration 
of keratinocytes in the normally pigmented epidermis of 
patients with vitiligo. J Invest Dermatol 1982;79:321-330.
5. Bhawan J, Bhutani LK. Keratinocyte damage in vitiligo. J 
Cutan Pathol 1983;10:207-212.
6. Yu HS, Kao CH, Yu CL. Coexistence and relationship of 
antikeratinocyte and antimelanocyte antibodies in patients 
with non-segmental-type vitiligo. J Invest Dermatol 1993; 
100:823-828.
7. Steinert PM, Idler WW, Zimmerman SB. Self-assembly of 
bovine epidermal keratin filaments in vitro. J Mol Biol 
1976;108:547-567.
8. Bowden PE, Wood EJ, Cunliffe WJ. Comparison of prekeratin 
and keratin polypeptides in normal and psoriatic human 
epidermis. Biochim Biophys Acta 1983;743:172-179.
9. Skerrow D, Hunter I. Protein modifications during the 
keratinization of normal and psoriatic human epidermis. 
Biochim Biophys Acta 1978;537:474-484.
10. Thompson CB. Apoptosis in the pathogenesis and treatment 
of disease. Science 1995;267:1456-1462.
11. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, 
Wyllie AH. Analysis and discrimination of necrosis and 
apoptosis (programmed cell death) by multiparameter flow 
cytometry. Biochim Biophys Acta 1992;1133:275-285.
12. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen 
RM, Pals ST, van Oers MH. Annexin V for flow cytometric 
detection of phosphatidylserine expression on B cells 
undergoing apoptosis. Blood 1994;84:1415-1420.
13. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van 
Schie RC, LaFace DM, et al. Early redistribution of plasma 
membrane phosphatidylserine is a general feature of 
apoptosis regardless of the initiating stimulus: inhibition by 
overexpression of Bcl-2 and Abl. J Exp Med 1995;182:1545- 
1556.
14. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, 
Reutelingsperger CP. Annexin V-affinity assay: a review on 
an apoptosis detection system based on phosphatidylserine 
exposure. Cytometry 1998;31:1-9.
15. Sun XM, Snowden RT, Skilleter DN, Dinsdale D, Ormerod 
MG, Cohen GM. A flow-cytometric method for the separa-
tion and quantitation of normal and apoptotic thymocytes. 
Anal Biochem 1992;204:351-356.
16. Guchelaar HJ, Vermes I, Koopmans RP, Reutelingsperger 
CP, Haanen C. Apoptosis- and necrosis-inducing potential of 
cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a 
quantitative pharmacodynamic model. Cancer Chemother 
Pharmacol 1998;42:77-83.
17. Mangili F, Cigala C, Santambrogio G. Staining apoptosis in 
paraffin sections. Advantages and limits. Anal Quant Cytol 
Histol 1999;21:273-276.
18. Lee AY, Youm YH, Kim NH, Yang H, Choi WI. Keratino-
cytes in the depigmented epidermis of vitiligo are more 
vulnerable to trauma (suction) than keratinocytes in the 
normally pigmented epidermis, resulting in their apoptosis. 
Br J Dermatol 2004;151:995-1003.
19. Moretti S, Fabbri P, Baroni G, Berti S, Bani D, Berti E, et al. 
Keratinocyte dysfunction in vitiligo epidermis: cytokine 
microenvironment and correlation to keratinocyte apoptosis. 
Histol Histopathol 2009;24:849-857.
20. Stennicke HR, Salvesen GS. Caspases - controlling intra-
cellular signals by protease zymogen activation. Biochim 
Biophys Acta 2000;1477:299-306.
21. Barnhart BC, Alappat EC, Peter ME. The CD95 type I/type II 
model. Semin Immunol 2003;15:185-193.
22. Weil M, Raff MC, Braga VM. Caspase activation in the 
terminal differentiation of human epidermal keratinocytes. 
Curr Biol 1999;9:361-364.
23. Bowen AR, Hanks AN, Allen SM, Alexander A, Diedrich MJ, 
Grossman D. Apoptosis regulators and responses in human 
melanocytic and keratinocytic cells. J Invest Dermatol 2003; 
120:48-55.
24. Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis - the 
p53 network. J Cell Sci 2003;116:4077-4085. 
25. Harada H, Grant S. Apoptosis regulators. Rev Clin Exp 
Hematol 2003;7:117-138.
26. Walczak H, Haas TL. Biochemical analysis of the native 
TRAIL death-inducing signaling complex. Methods Mol Biol 
2008;414:221-239.
27. Dupré A, Christol B. Cockade-like vitiligo and linear vitiligo 
a variant of fitzpatrick's trichrome vitiligo. Arch Dermatol 
Res 1978;262:197-203.
28. Gauthier Y, Cario-Andre M, Lepreux S, Pain C, Taïeb A. AY Lee
124 Ann Dermatol
Melanocyte detachment after skin friction in non lesional 
skin of patients with generalized vitiligo. Br J Dermatol 
2003;148:95-101. 
29. Badri AM, Todd PM, Garioch JJ, Gudgeon JE, Stewart DG, 
Goudie RB. An immunohistological study of cutaneous 
lymphocytes in vitiligo. J Pathol 1993;170:149-155.
30. van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, 
Tigges B, Westerhof W, Das P. Local immune response in 
skin of generalized vitiligo patients. Destruction of melano-
cytes is associated with the prominent presence of CLA+ T 
cells at the perilesional site. Lab Invest 2000;80:1299-1309.
31. Wańkowicz-Kalińska A, van den Wijngaard RM, Tigges BJ, 
Westerhof W, Ogg GS, Cerundolo V, et al. Immuno-
polarization of CD4+ and CD8+ T cells to Type-1-like is 
associated with melanocyte loss in human vitiligo. Lab 
Invest 2003;83:683-695.
32. van den Boorn JG, Konijnenberg D, Dellemijn TA, van der 
Veen JP, Bos JD, Melief CJ, et al. Autoimmune destruction of 
skin melanocytes by perilesional T cells from vitiligo 
patients. J Invest Dermatol 2009;129:2220-2232. 
33. Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, 
Fabiani M, et al. New insights into the pathogenesis of 
vitiligo: imbalance of epidermal cytokines at sites of lesions. 
Pigment Cell Res 2002;15:87-92.
34. Birol A, Kisa U, Kurtipek GS, Kara F, Kocak M, Erkek E, et al. 
Increased tumor necrosis factor alpha (TNF- alpha) and 
interleukin 1 alpha (IL1-alpha) levels in the lesional skin of 
patients with nonsegmental vitiligo. Int J Dermatol 2006;45: 
992-993.
35. Gordon PR, Mansur CP, Gilchrest BA. Regulation of human 
melanocyte growth, dendricity, and melanization by kera-
tinocyte derived factors. J Invest Dermatol 1989;92:565-572.
36. Rossi D, Gaidano G. Messengers of cell death: apoptotic 
signaling in health and disease. Haematologica 2003;88: 
212-218.
37. Tartaglia LA, Pennica D, Goeddel DV. Ligand passing: the 
75-kDa tumor necrosis factor (TNF) receptor recruits TNF for 
signaling by the 55-kDa TNF receptor. J Biol Chem 1993; 
268:18542-18548.
38. Kim NH, Jeon S, Lee HJ, Lee AY. Impaired PI3K/Akt 
activation-mediated NF-kappaB inactivation under elevated 
TNF-alpha is more vulnerable to apoptosis in vitiliginous 
keratinocytes. J Invest Dermatol 2007;127:2612-2617. 
39. Fulda S, Strauss G, Meyer E, Debatin KM. Functional CD95 
ligand and CD95 death-inducing signaling complex in 
activation-induced cell death and doxorubicin-induced 
apoptosis in leukemic T cells. Blood 2000;95:301-308.
40. Lu B, Wang L, Stehlik C, Medan D, Huang C, Hu S, et al. 
Phosphatidylinositol 3-kinase/Akt positively regulates Fas 
(CD95)-mediated apoptosis in epidermal Cl41 cells. J Immu-
nol 2006;176:6785-6793.
41. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, et 
al. Caspase cleaved BID targets mitochondria and is required 
for cytochrome c release, while BCL-XL prevents this release 
but not tumor necrosis factor-R1/Fas death. J Biol Chem 
1999;274:1156-1163.
42. Singh R, Pervin S, Chaudhuri G. Caspase-8-mediated BID 
cleavage and release of mitochondrial cytochrome c during 
Nomega-hydroxy-L-arginine-induced apoptosis in MDA-MB- 
468 cells. Antagonistic effects of L-ornithine. J Biol Chem 
2002;277:37630-37636. 
43. Li T, Lu C, Xia Z, Xiao B, Luo Y. Inhibition of caspase-8 
attenuates neuronal death induced by limbic seizures in a 
cytochrome c-dependent and Smac/DIABLO-independent 
way. Brain Res 2006;1098:204-211. 
44. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, 
Donner DB. NF-kappaB activation by tumour necrosis factor 
requires the Akt serine-threonine kinase. Nature 1999;401: 
82-85.
45. Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and 
TRADD-FADD interactions define two distinct TNF receptor 
1 signal transduction pathways. Cell 1996;84:299-308.
46. Wallach D, Boldin MP, Kovalenko AV, Malinin NL, Mett IL, 
Camonis JH. The yeast two-hybrid screening technique and 
its use in the study of protein-protein interactions in 
apoptosis. Curr Opin Immunol 1998;10:131-136.
47. Thrash BR, Menges CW, Pierce RH, McCance DJ. AKT1 
provides an essential survival signal required for differen-
tiation and stratification of primary human keratinocytes. J 
Biol Chem 2006;281:12155-12162. 
48. Calautti E, Li J, Saoncella S, Brissette JL, Goetinck PF. Phos-
phoinositide 3-kinase signaling to Akt promotes keratinocyte 
differentiation versus death. J Biol Chem 2005;280:32856- 
32865. 
49. Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, 
Werb Z, et al. Epithelial immaturity and multiorgan failure in 
mice lacking epidermal growth factor receptor. Nature 
1995;376:337-341.
50. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, 
Jacobs J, et al. Dwarfism, impaired skin development, 
skeletal muscle atrophy, delayed bone development, and 
impeded adipogenesis in mice lacking Akt1 and Akt2. 
Genes Dev 2003;17:1352-1365.
51. Kim NH, Lee AY. Reduced aquaporin3 expression and 
survival of keratinocytes in the depigmented epidermis of 
vitiligo. J Invest Dermatol 2010;130:2231-2239. 
52. Xie Z, Bikle DD. The recruitment of phosphatidylinositol 
3-kinase to the E-cadherin-catenin complex at the plasma 
membrane is required for calcium-induced phospholipase 
C-gamma1 activation and human keratinocyte differentiation. 
J Biol Chem 2007;282:8695-8703. 
53. Janes SM, Ofstad TA, Campbell DH, Watt FM, Prowse DM. 
Transient activation of FOXN1 in keratinocytes induces a 
transcriptional programme that promotes terminal differen-
tiation: contrasting roles of FOXN1 and Akt. J Cell Sci 2004; 
117:4157-4168.
54. Fuchs E, Raghavan S. Getting under the skin of epidermal 
morphogenesis. Nat Rev Genet 2002;3:199-209.
55. Tinkle CL, Pasolli HA, Stokes N, Fuchs E. New insights into 
cadherin function in epidermal sheet formation and 
maintenance of tissue integrity. Proc Natl Acad Sci U S A 
2008;105:15405-15410. 
56. Frigeri A, Gropper MA, Turck CW, Verkman AS. Immuno-
localization of the mercurial-insensitive water channel and Keratinocyte Role in Vitiligo
Vol. 24, No. 2, 2012 125
glycerol intrinsic protein in epithelial cell plasma mem-
branes. Proc Natl Acad Sci U S A 1995;92:4328-4331.
57. Sougrat R, Morand M, Gondran C, Barré P, Gobin R, Bonté 
F, et al. Functional expression of AQP3 in human skin 
epidermis and reconstructed epidermis. J Invest Dermatol 
2002;118:678-685.
58. Nejsum LN, Nelson WJ. A molecular mechanism directly 
linking E-cadherin adhesion to initiation of epithelial cell 
surface polarity. J Cell Biol 2007;178:323-335.
59. Gauthier Y, Cario-Andre M, Lepreux S, Pain C, Taïeb A. 
Melanocyte detachment after skin friction in non lesional 
skin of patients with generalized vitiligo. Br J Dermatol 
2003;148:95-101.
60. Lee AY, Kim NH, Choi WI, Youm YH. Less keratinocyte- 
derived factors related to more keratinocyte apoptosis in 
depigmented than normally pigmented suction-blistered 
epidermis may cause passive melanocyte death in vitiligo. J 
Invest Dermatol 2005;124:976-983.
61. Hirobe T. Role of keratinocyte-derived factors involved in 
regulating the proliferation and differentiation of mammalian 
epidermal melanocytes. Pigment Cell Res 2005;18:2-12.
62. Morita E, Lee DG, Sugiyama M, Yamamoto S. Expression of 
c-kit ligand in human keratinocytes. Arch Dermatol Res 
1994;286:273-277.
63. Hachiya A, Kobayashi A, Ohuchi A, Takema Y, Imokawa G. 
The paracrine role of stem cell factor/c-kit signaling in the 
activation of human melanocytes in ultraviolet-B-induced 
pigmentation. J Invest Dermatol 2001;116:578-586.
64. Hirobe T, Osawa M, Nishikawa S. Steel factor controls the 
proliferation and differentiation of neonatal mouse epider-
mal melanocytes in culture. Pigment Cell Res 2003;16:644- 
655.
65. Kunisada T, Lu SZ, Yoshida H, Nishikawa S, Nishikawa S, 
Mizoguchi M, et al. Murine cutaneous mastocytosis and 
epidermal melanocytosis induced by keratinocyte expre-
ssion of transgenic stem cell factor. J Exp Med 1998;187: 
1565-1573.
66. Longley BJ Jr, Morganroth GS, Tyrrell L, Ding TG, Anderson 
DM, Williams DE, et al. Altered metabolism of mast-cell 
growth factor (c-kit ligand) in cutaneous mastocytosis. N 
Engl J Med 1993;328:1302-1307.
67. Welker P, Grabbe J, Gibbs B, Zuberbier T, Henz BM. 
Human mast cells produce and differentially express both 
soluble and membrane-bound stem cell factor. Scand J 
Immunol 1999;49:495-500.
68. Jacobsen MD, Weil M, Raff MC. Role of Ced-3/ICE-family 
proteases in staurosporine-induced programmed cell death. J 
Cell Biol 1996;133:1041-1051.
69. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological 
phenomenon with wide-ranging implications in tissue 
kinetics. Br J Cancer 1972;26:239-257.
70. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of 
apoptosis. Int Rev Cytol 1980;68:251-306.
71. Ledda-Columbano GM, Columbano A, Coni P, Faa G, Pani 
P. Cell deletion by apoptosis during regression of renal 
hyperplasia. Am J Pathol 1989;135:657-662.